A central role of CCR2 in TAM accumulation is supported by data showing high levels of tumour-derived CCR2 concurrent with leukocyte recruitment in several cancer types, including mammary [39], pancreatic [86], and prostate carcinoma [87]. This evidence concerns the gene CCR2 and prostate carcinoma.